Significant Ownership of Samsara BioCapital, L.P.

Signature - Title
/s/ Srinivas Akkaraju - By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Samsara BioCapital, L.P..

Notify me when Samsara BioCapital, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Samsara BioCapital, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KLRS KALARIS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share 56% $90,804,603 +$10,553,555 12,953,581 +13% Srinivas Akkaraju 22 Dec 2025
VTVT VTV THERAPEUTICS INC. Class A Common Stock, par value $0.01 per share 9.9% $12,001,117 +$1,803,961 403,942 +18% Srinivas Akkaraju 08 Dec 2025
RANI RANI THERAPEUTICS HOLDINGS, INC. Class A Common Stock, $0.0001 par value per share 9.9% $4,939,262 9,882,477 Srinivas Akkaraju 23 Oct 2025
MLYS MINERALYS THERAPEUTICS, INC. Common Stock 8.2% $85,419,771 +$8,209,106 6,346,194 +11% Srinivas Akkaraju 04 Sep 2025
IVA Inventiva S.A. Ordinary shares, nominal value (euro) 0.01 per share 7.4% $56,191,805 +$22,319,746 13,540,194 +66% Srinivas Akkaraju 17 Nov 2025
SRRK SCHOLAR ROCK HOLDING CORP Common Stock, par value $0.001 per share 7.2% $260,368,230 6,991,553 Srinivas Akkaraju 03 Oct 2025
SPYGLASS PHARMA, INC. Common Stock, $0.00001 par value per share 6.3% 2,109,953 Srinivas Akkaraju 09 Feb 2026
ALMS ALUMIS INC. Common Stock, $0.0001 par value per share 5.4% $61,929,972 +$11,811,946 6,345,219 +24% Srinivas Akkaraju 09 Jan 2026
NKTX NKARTA, INC. Common Stock, $0.0001 par value per share 4.9% $8,383,322 3,507,666 Samsara BioCapital, L.P. 20 Nov 2025
IOBT IO Biotech, Inc. Common Stock, $0.001 par value per share 3.8% $2,578,946 2,631,578 Samsara BioCapital, L.P. 31 Dec 2024
PVLA Palvella Therapeutics, Inc. Common Stock, $0.001 par value per share 3.1% $8,989,600 -$8,989,600 339,743 -50% Samsara BioCapital, L.P. 30 Jun 2025
SYRS Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 2.6% $21,213 707,114 Samsara BioCapital, L.P. 18 Nov 2024
OKUR OnKure Therapeutics, Inc. Class A Common Stock, par value $0.0001 per share 0% $0 0 Samsara BioCapital, L.P. 30 Jun 2025
LPTX Leap Therapeutics, Inc. Common stock, $0.001 par value per share 0% $0 0 Samsara BioCapital, L.P. 30 Jun 2025
CRGX CARGO THERAPEUTICS, INC. Common Stock, par value $0.001 0% $0 0 Samsara BioCapital, L.P. 30 Sep 2025

Schedules 13D/G Reported by Samsara BioCapital, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.